Primary Site >> Colorectal Cancer
Gene >> SATB2
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|
|
Ref: Down-regulated expression of SATB2 is associated with metastasis and poor prognosis in colorectal cancer. PMID: 19557828 |
Ref: SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas. PMID: 21677534 |
Ref: A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer. PMID: 22333599 Ref: Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer. PMID: 22935204 |
Ref: Elevated microRNA-31 expression regulates colorectal cancer progression by repressing its target gene SATB2. PMID: 24386467 |
Ref: Cadherin-17 and SATB2 are sensitive and specific immunomarkers for medullary carcinoma of the large intestine. PMID: 24437456 Ref: The role of SATB2 as a diagnostic marker for tumors of colorectal origin: Results of a pathology-based clinical prospective study. PMID: 24713733 Ref: microRNA-182 targets special AT-rich sequence-binding protein 2 to promote colorectal cancer proliferation and metastasis. PMID: 24884732 Ref: Expression of SATB1 promotes the growth and metastasis of colorectal cancer. PMID: 24971456 Ref: Prognostic and treatment predictive significance of SATB1 and SATB2 expression in pancreatic and periampullary adenocarcinoma. PMID: 25323550 |
Ref: Special AT-rich sequence-binding protein 2 suppresses invadopodia formation in HCT116 cells via palladin inhibition. PMID: 25523619 Ref: SATB1 and 2 in colorectal cancer. PMID: 25543122 Ref: SATB2 suppresses the progression of colorectal cancer cells via inactivation of MEK5/ERK5 signaling. PMID: 25662172 Ref: The value of SATB2 in the differential diagnosis of intestinal-type mucinous tumors of the ovary: primary vs metastatic. PMID: 26059401 Ref: [Diagnostic value of SATB2, CK7 and CK20 in colorectal cancer]. PMID: 26705182 |
Ref: SATB1 and SATB2 play opposing roles in c-Myc expression and progression of colorectal cancer. PMID: 26701851 Ref: Value of SATB2 immunostaining in the distinction between small intestinal and colorectal adenocarcinomas. PMID: 27169755 Ref: Special AT-rich sequence-binding protein 2 acts as a negative regulator of stemness in colorectal cancer cells. PMID: 27784965 |
Ref: Clinicopathological, immunohistochemical, and mutational analyses of pulmonary enteric adenocarcinoma: usefulness of SATB2 and beta-catenin immunostaining for differentiation from metastatic colorectal carcinoma. PMID: 28438615 Ref: Differentiation of Human Pluripotent Stem Cells into Colonic Organoids via Transient Activation of BMP Signaling. PMID: 28648364 Ref: SATB2/beta-catenin/TCF-LEF pathway induces cellular transformation by generating cancer stem cells in colorectal cancer. PMID: 28887549 Ref: miR-449a inhibits colorectal cancer progression by targeting SATB2. PMID: 29254139 Ref: A Comprehensive Evaluation of Special AT-rich Sequence-binding Protein 2 (SATB2) Immunohistochemical Staining in Mucinous Tumors From Gastrointestinal and Nongastrointestinal Sites. PMID: 29271791 |
Ref: The Role of SATB2 as a Diagnostic Marker of Sinonasal Intestinal-type Adenocarcinoma. PMID: 27258560 Ref: SATB2 is a Promising Biomarker for Identifying a Colorectal Origin for Liver Metastatic Adenocarcinomas. PMID: 29396302 Ref: CK7/CK20 Double-Negative Pulmonary Enteric Adenocarcinoma With Histopathological Evaluation of Transformation Zone Between Enteric Adenocarcinoma and Conventional Pulmonary Adenocarcinoma. PMID: 29411669 Ref: Dual Stain With SATB2 and CK20/Villin Is Useful to Distinguish Colorectal Carcinomas From Other Tumors. PMID: 29471325 Ref: SATB2 targeted by methylated miR-34c-5p suppresses proliferation and metastasis attenuating the epithelial-mesenchymal transition in colorectal cancer. PMID: 29701273 Ref: SATB2 is a supplementary immunohistochemical marker to CDX2 in the diagnosis of colorectal carcinoma metastasis in an unknown primary. PMID: 29924451 Ref: Loss of SATB2 Expression in Colorectal Carcinoma Is Associated With DNA Mismatch Repair Protein Deficiency and BRAF Mutation. PMID: 30001238 Ref: Sigmoid Colon Adenocarcinoma with Isolated Loss of PMS2 Presenting in a Patient with Synchronous Prostate Cancer with Intact MMR: Diagnosis and Analysis of the Family Pedigree. PMID: 30061258 Ref: Cellular localization of PD-L1 expression in mismatch-repair-deficient and proficient colorectal carcinomas. PMID: 30166615 Ref: SATB2 is Superior to CDX2 in Distinguishing Signet Ring Cell Carcinoma of the Upper Gastrointestinal Tract and Lower Gastrointestinal Tract. PMID: 30212392 Ref: Pathologic differential diagnosis of metastatic carcinoma in the liver. PMID: 30300991 Ref: miR3666 suppresses cellular proliferation and invasion in colorectal cancer by targeting SATB2. PMID: 30320357 |